Cargando…
Estimación de la demanda de medicamentos antichagásicos: una contribución para el acceso en América Latina
OBJECTIVE. Describe a tool to estimate demand for benznidazole and nifurtimox to treat Chagas disease, and report on its implementation in a group of Latin American countries. METHODS. The project was carried out in the following stages: 1) development of a tool to estimate demand, and definition of...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Organización Panamericana de la Salud
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612731/ https://www.ncbi.nlm.nih.gov/pubmed/28614468 http://dx.doi.org/10.26633/RPSP.2017.45 |
_version_ | 1783432925986947072 |
---|---|
author | Costa Chaves, Gabriela Abi-Saab Arrieche, Mariana Rode, Joelle Mechali, Daniel Ouverney Reis, Priscileyne Vieira Alves, Renato Stobbaerts, Eric Girón Aguilar, Nora Ribeiro, Isabela |
author_facet | Costa Chaves, Gabriela Abi-Saab Arrieche, Mariana Rode, Joelle Mechali, Daniel Ouverney Reis, Priscileyne Vieira Alves, Renato Stobbaerts, Eric Girón Aguilar, Nora Ribeiro, Isabela |
author_sort | Costa Chaves, Gabriela |
collection | PubMed |
description | OBJECTIVE. Describe a tool to estimate demand for benznidazole and nifurtimox to treat Chagas disease, and report on its implementation in a group of Latin American countries. METHODS. The project was carried out in the following stages: 1) development of a tool to estimate demand, and definition of the evaluation and decision variables to estimate demand 2) data collection via a questionnaire completed by representatives of control programs, complemented with data from the literature; 3) presentation of the tool, followed by validation, and adaptation by representatives of the control programs in order to plan drug procurement for 2012 and 2013; and 4) further analysis of the obtained data, especially regarding benznidazole, and comparison of country estimates. RESULTS. Fourteen endemic countries of Latin America took part in the third stage, and a consolidated estimate was made. The number of estimated treatments, based on the number of tablets per treatment established in the regimen of reference was: 867 in the group under 1 year of age; 2 042 835 in the group from 1 to 15 years old; 2 028 in the group from 15 to 20 years old; and 10 248 in adults over 20. This means that it is possible to provide benznidazole to less than 1% of people for whom treatment is indicated. CONCLUSIONS. The development and systematic use of demand management tools can play a key role in helping to provide access to the anti-Chagas drugs. There is a significant gap between the projected demand for drugs and current estimates of prevalence rates. |
format | Online Article Text |
id | pubmed-6612731 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Organización Panamericana de la Salud |
record_format | MEDLINE/PubMed |
spelling | pubmed-66127312019-07-30 Estimación de la demanda de medicamentos antichagásicos: una contribución para el acceso en América Latina Costa Chaves, Gabriela Abi-Saab Arrieche, Mariana Rode, Joelle Mechali, Daniel Ouverney Reis, Priscileyne Vieira Alves, Renato Stobbaerts, Eric Girón Aguilar, Nora Ribeiro, Isabela Rev Panam Salud Publica Informe Especial OBJECTIVE. Describe a tool to estimate demand for benznidazole and nifurtimox to treat Chagas disease, and report on its implementation in a group of Latin American countries. METHODS. The project was carried out in the following stages: 1) development of a tool to estimate demand, and definition of the evaluation and decision variables to estimate demand 2) data collection via a questionnaire completed by representatives of control programs, complemented with data from the literature; 3) presentation of the tool, followed by validation, and adaptation by representatives of the control programs in order to plan drug procurement for 2012 and 2013; and 4) further analysis of the obtained data, especially regarding benznidazole, and comparison of country estimates. RESULTS. Fourteen endemic countries of Latin America took part in the third stage, and a consolidated estimate was made. The number of estimated treatments, based on the number of tablets per treatment established in the regimen of reference was: 867 in the group under 1 year of age; 2 042 835 in the group from 1 to 15 years old; 2 028 in the group from 15 to 20 years old; and 10 248 in adults over 20. This means that it is possible to provide benznidazole to less than 1% of people for whom treatment is indicated. CONCLUSIONS. The development and systematic use of demand management tools can play a key role in helping to provide access to the anti-Chagas drugs. There is a significant gap between the projected demand for drugs and current estimates of prevalence rates. Organización Panamericana de la Salud 2017-04-14 /pmc/articles/PMC6612731/ /pubmed/28614468 http://dx.doi.org/10.26633/RPSP.2017.45 Text en https://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Informe Especial Costa Chaves, Gabriela Abi-Saab Arrieche, Mariana Rode, Joelle Mechali, Daniel Ouverney Reis, Priscileyne Vieira Alves, Renato Stobbaerts, Eric Girón Aguilar, Nora Ribeiro, Isabela Estimación de la demanda de medicamentos antichagásicos: una contribución para el acceso en América Latina |
title | Estimación de la demanda de medicamentos antichagásicos: una contribución para el acceso en América Latina |
title_full | Estimación de la demanda de medicamentos antichagásicos: una contribución para el acceso en América Latina |
title_fullStr | Estimación de la demanda de medicamentos antichagásicos: una contribución para el acceso en América Latina |
title_full_unstemmed | Estimación de la demanda de medicamentos antichagásicos: una contribución para el acceso en América Latina |
title_short | Estimación de la demanda de medicamentos antichagásicos: una contribución para el acceso en América Latina |
title_sort | estimación de la demanda de medicamentos antichagásicos: una contribución para el acceso en américa latina |
topic | Informe Especial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612731/ https://www.ncbi.nlm.nih.gov/pubmed/28614468 http://dx.doi.org/10.26633/RPSP.2017.45 |
work_keys_str_mv | AT costachavesgabriela estimaciondelademandademedicamentosantichagasicosunacontribucionparaelaccesoenamericalatina AT abisaabarriechemariana estimaciondelademandademedicamentosantichagasicosunacontribucionparaelaccesoenamericalatina AT rodejoelle estimaciondelademandademedicamentosantichagasicosunacontribucionparaelaccesoenamericalatina AT mechalidaniel estimaciondelademandademedicamentosantichagasicosunacontribucionparaelaccesoenamericalatina AT ouverneyreispriscileyne estimaciondelademandademedicamentosantichagasicosunacontribucionparaelaccesoenamericalatina AT vieiraalvesrenato estimaciondelademandademedicamentosantichagasicosunacontribucionparaelaccesoenamericalatina AT stobbaertseric estimaciondelademandademedicamentosantichagasicosunacontribucionparaelaccesoenamericalatina AT gironaguilarnora estimaciondelademandademedicamentosantichagasicosunacontribucionparaelaccesoenamericalatina AT ribeiroisabela estimaciondelademandademedicamentosantichagasicosunacontribucionparaelaccesoenamericalatina |